Cargando…
HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells
Human antigen (Hu) R is an RNA-binding protein whose overexpression in human cancer correlates with aggressive disease, drug resistance, and poor prognosis. HuR inhibition has profound anticancer activity. Pharmacologic inhibitors can overcome the limitations of genetic inhibition. In this study, we...
Autores principales: | Muralidharan, Ranganayaki, Mehta, Meghna, Ahmed, Rebaz, Roy, Sudeshna, Xu, Liang, Aubé, Jeffrey, Chen, Allshine, Zhao, Yan Daniel, Herman, Terence, Ramesh, Rajagopal, Munshi, Anupama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577245/ https://www.ncbi.nlm.nih.gov/pubmed/28855578 http://dx.doi.org/10.1038/s41598-017-07787-4 |
Ejemplares similares
-
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration
por: Muralidharan, Ranganayaki, et al.
Publicado: (2016) -
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration, and invasion in lung cancer
por: Muralidharan, Ranganayaki, et al.
Publicado: (2015) -
Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells
por: Ahmed, Rebaz, et al.
Publicado: (2021) -
HuR Reduces Radiation-Induced DNA Damage by Enhancing Expression of ARID1A
por: Andrade, Daniel, et al.
Publicado: (2019) -
HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy
por: Mehta, Meghna, et al.
Publicado: (2016)